FOR IMMEDIATE RELEASE
Hepatitis B Foundation Bids Farewell to Executive Director Molli Conti
A National Leader in Advocating for Those Affected by Hepatitis B
DOYLESTOWN, PA (August 13, 2007) – The Hepatitis B Foundation Board of Directors announced today that Executive Director Molli Conti is leaving the organization as of September 1, 2007. Ms. Conti is a respected leader in the world of viral hepatitis and has been actively engaged at the local and national level to promote hepatitis B awareness for almost a decade. Based on her experience and professional accomplishments, she was offered an exciting leadership opportunity within the pharmaceutical industry to help create a new national advocacy program for hepatitis B.
Under Ms. Conti’s leadership, the Hepatitis B Foundation has gained recognition as a leading authority on hepatitis B and as a world-class research organization dedicated to this serious liver disease. Through its state-of-the art research institute, comprehensive outreach program, and public health research initiatives, the Foundation seeks to fulfill its mission of finding a cure and helping to improve the quality of life of those affected worldwide.
"I'm proud to have been a part of such an impressive nonprofit research organization," said Ms. Conti. "During my eight years at the Hepatitis B Foundation, I have been privileged to participate in its enormous growth and I am excited about the future of the Hepatitis B Foundation. We are truly bringing hope to the 400 million people who live with chronic hepatitis B worldwide, through the dedicated work of our researchers and public health professionals.”
According to Hepatitis B Foundation President Dr. Timothy Block, “We are lucky to have had Molli at the Foundation for as long as we did because she was the right person to help lead us through one of the most significant growth periods in our history. The Foundation is very proud that she has become a national authority on viral hepatitis. We all wish her great success in her new position where she will continue to do what she does so well – to advocate for hepatitis B as an urgent public health priority.”
As the Foundation’s Executive Director, Ms. Conti served for the past two years as Chair of the National Viral Hepatitis Roundtable (NVHR), which is a coalition of 120 organizations that published the first-ever national strategic plan to eliminate viral hepatitis in the United States in May 2006. She also serves on the board of the Delaware Valley HepTREC, the executive committee of the National Task Force on Hepatitis B: Focus on Asian and Pacific Islander Americans, and the advisory board of the Pennsylvania Department of Health’s Viral Hepatitis Coalition.
In addition to spearheading national advocacy initiatives, Ms. Conti has been co-author of several publications on hepatitis B in professional journals; principal investigator for National Institutes of Health and U.S. Department of Education grants; and a sought-after expert speaker at national meetings on viral hepatitis.
Ms. Conti graduated with a B.S. in Community Development from Penn State University, serves as President of the Board for the James A. Michener Museum, and resides with her husband in Bucks County, PA.
About the Hepatitis B Foundation
The Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through research, education and patient advocacy. It is located in the new Pennsylvania Biotechnology Center that it created to accelerate its research progress. For more information, visit www.hepb.org or call (215) 489-4900.